The Aim of the Healthcare Committee of AmCham Estonia is to provide Estonian policymakers, institutions and other relevant stakeholders with the perspective of US companies that operate in Estonia. Health is an important driver for wealth and economic growth. The Committee therefore would support the EU health agenda towards affordable, sustainable and innovative health systems. Composed of the various healthcare industries (pharmaceuticals, eHealth, medical devices, consumer, and transport industries), it would to be a reliable policy partner to the Estonian institutions and to help ensure that new healthcare-related legislations and policies add value to, and benefit, the entire healthcare ecosystem.
To view the latest position paper by the AmCham Healthcare Committee please CLICK HERE
Committee Members:
-
- Elo Tamm, COBALT Law Office (Committee Chair)
- Hanno Püttsepp, Amgen (Committee Co-Chair)
- Liudvika Starkiene, Amgen
- Daria Sivovol, AmCham Estonia
- Madis Aaren, AbbVie
- Sonata Matuleviciene, AstraZeneca
- Pille Pihlakas, AstraZeneca
- Triin Parik, AstraZeneca
- Daniela Pavlic, AstraZeneca
- Martin Minin, Semetron (Medical Devices)
- Siiri Võlu-Tiganik, HansaMedical OÜ (Medical Devices)
- Kärt Tali, Bayer
- Edgars Skvariks, Bayer
- Mikko Fernström, Biogen
- Andrei Nahkala, Biogen
- Jolanta Dickute, Biogen
- Piibe Veiram, Biogen
- Rima Valentukeviciene, IBM
- Michal Pilkiewicz, IQVIA
- Kaspars Grosu, IQVIA
- Andrius Girzadas, IQVIA
- Jane Kesküla, Johnson & Johnson
- Laura Saar, Johnson & Johnson
- Kairit Sildre, Johnson & Johnson
- Giedre Kuldmäe, Johnson & Johnson (MedTech)
- Tarmo Toiger, KPMG
- Vladimir Ossipov, Marsh
- Marit Järv, Marsh
- Margus Läänesaar, Medtronic
- Andrius Grigosaitis, Medtronic
- Ruthy Kaidar, Microsoft
- Ema Popova, Microsoft
- Svetlana Nikkinen, Microsoft
- Imants Sinka, MSD
- Kadri Päll, MSD
- Andres Müürsepp, MSD
- Pille Loit, M-Ring
- Marki-Tihhonova-Kreek, Nortal
- Karin Varrak, Novartis
- Rudolf Põld, Novartis
- Alice Kivistik, Pfizer
- Anneli Truhanov, Pfizer
- Mart Vain, Roche
- Kadri Mägi-Lehtsi, Roche
- Evita Feldberga, Roche
- Lise-Lotte Lääne, Sorainen
- Merilin Varsamaa, Tallinn Science Park Tehnopol
- Taimi Veedla, U.S. Embassy Tallinn
- Ingeri Luik-Tamme, TGS Baltics
2024 Highlights:
- AmCham Healthcare Forum “Resilience and Funding of the Estonian Healthcare System.”
- Interview with Niilo Färkkilä
- Interview with Janko Burgar
- Media Coverage of the AmCham Healthcare Forum 2024
2023 Highlights:
- AmCham Round-Table on Vaccination Confidence
- AmCham Annual Healthcare Conference 2023
- AmCham Round-Table on Vaccination Confidence #2
AmCham Healthcare Committee meeting 2021/1
AmCham Healthcare Committee Round Table Meeting
Amcham Healthcare Committee Meets with the Social Ministry Representative
Healthcare Committee Meets with the Social Ministry Representatives
Healthcare Committee Meets with the New Chairman of the Board of HIF, Rain Laane
AmCham Healthcare Committee Meets for its 3rd Meeting
AmCham Healthcare Committee Position Paper
Here are some of the most relevant issues the committee was addressing in 2019:
Based on many recent and not so recent studies Estonian healthcare financing system (lack of funds in EHIF) is not sustainable in the changed environment (aging population, increased expectation, innovation in HC etc). The committee is trying to identify what are the short and long term plans to make the Estonian HC future-proof.
In approximately half of the European countries, Value Added Tax of prescription medicines is lower than in Estonia (for example 6% in the Netherlands, 5% in Lithuania, 4% in Spain, 2,1% in France compared to 9% in Estonia). High proportional VAT increases especially the price of innovative new pharmaceuticals, creates an additional burden to the Health Insurance Fund and restricts access to new treatments for Estonian patients. The committee is trying to offer a change in the taxation system in order to address the issue.
Background: Today we are measuring healthcare by different input KPIs (number of nights in the hospital, cost of treatment procedures or process quality KPIs (waiting list for medical treatment), but instead we should measure and incentivize patient-centric quality of life KPIs like social functioning, self-care etc. Those KPIs have been developed and validated internationally (https://www.ichom.org/standard-sets/), but none of the countries haven’t yet implemented those nationwide. Estonia could be the leader here, as we do have digital capabilities and we are small. The committee is trying to promote the support of establishing or piloting patient-centric value-based healthcare.
Please find the newest AmCham Member offers below, more discount partner programs can be found by clicking the link below.
Please find the newest AmCham Member offers below, more discount partner programs can be found by clicking the link below.